Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raymond

Showing results (471-480 of 1,063) with videos related to

Pageof 107
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable AlterationsSiddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2008
Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding modeM Raymond V Finlay, David G Acton, David M Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic CancerSeyed Pairawan, Kenneth R Hess, Filip Janku, et al.
Circulation. Heart Failure|March 31, 2025
Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic CardiomyopathyFilippo Pinto E Vairo, Jeffrey B Geske, Ravinder J Singh, et al.
JCO Precision Oncology|July 1, 2026
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC StudyTatsuro Murano, Hiroaki Ikematsu, Nobuhisa Matsuhashi, et al.
CNS Oncology|March 12, 2019
Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumorsDavid E Piccioni, Achal Singh Achrol, Lesli A Kiedrowski, et al.
International Journal of Neonatal Screening|August 18, 2020
A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage DisordersKaren A Sanders, Dimitar K Gavrilov, Devin Oglesbee, et al.
Journal of Medicinal Chemistry|February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Journal of Medicinal Chemistry|December 19, 2019
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)amino]-9-(tetrahydro-2<i>H</i>-pyran-4-yl)-7,9-dihydro-8<i>H</i>-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) InhibitorFrederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, et al.
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With <i>IDH</i>-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
Pageof 107

Showing results (471-480 of 1,063) with videos related to

Sort By:
Pageof 107
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable AlterationsSiddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2008
Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding modeM Raymond V Finlay, David G Acton, David M Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic CancerSeyed Pairawan, Kenneth R Hess, Filip Janku, et al.
Circulation. Heart Failure|March 31, 2025
Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic CardiomyopathyFilippo Pinto E Vairo, Jeffrey B Geske, Ravinder J Singh, et al.
JCO Precision Oncology|July 1, 2026
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC StudyTatsuro Murano, Hiroaki Ikematsu, Nobuhisa Matsuhashi, et al.
CNS Oncology|March 12, 2019
Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumorsDavid E Piccioni, Achal Singh Achrol, Lesli A Kiedrowski, et al.
International Journal of Neonatal Screening|August 18, 2020
A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage DisordersKaren A Sanders, Dimitar K Gavrilov, Devin Oglesbee, et al.
Journal of Medicinal Chemistry|February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Journal of Medicinal Chemistry|December 19, 2019
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)amino]-9-(tetrahydro-2<i>H</i>-pyran-4-yl)-7,9-dihydro-8<i>H</i>-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) InhibitorFrederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, et al.
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With <i>IDH</i>-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
Pageof 107